Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues [Abstract]
Revenue	$ 104,762,000	$ 57,794,000	$ 266,927,000	$ 199,070,000
Operating expenses:
Cost of revenue (excluding amortization and depreciation)	8,437,000	6,532,000	22,789,000	18,687,000
Research and development	45,388,000	28,767,000	132,071,000	67,141,000
Selling, general and administrative	95,564,000	83,188,000	298,088,000	236,314,000
Loss in fair value of contingent consideration	16,391,000	(180,000)	17,139,000	5,711,000
Intangible asset amortization	1,606,000	1,607,000	4,785,000	4,768,000
Total operating expenses	167,386,000	119,914,000	474,872,000	332,621,000
Loss from operations	(62,624,000)	(62,120,000)	(207,945,000)	(133,551,000)
Interest expense, net	(1,978,000)	(757,000)	(4,359,000)	(5,751,000)
Loss before income taxes	(64,602,000)	(62,877,000)	(212,304,000)	(139,302,000)
Income tax benefit (expense)	0	678,000	0	(1,285,000)
Net loss	$ (64,602,000)	$ (62,199,000)	$ (212,304,000)	$ (140,587,000)
Net loss per common share, basic	$ (1.34)	$ (1.32)	$ (4.45)	$ (3.14)
Net loss per common share, diluted	$ (1.34)	$ (1.32)	$ (4.45)	$ (3.14)
Weighted average common shares outstanding, basic	48,140,519	47,117,196	47,703,508	44,783,380
Weighted average common shares outstanding, diluted	48,140,519	47,117,196	47,703,508	44,783,380
Product Sales
Revenues [Abstract]
Revenue	$ 103,736,000	$ 57,127,000	$ 264,352,000	$ 131,713,000
License Revenue
Revenues [Abstract]
Revenue				65,735,000
Royalty Revenue
Revenues [Abstract]
Revenue	$ 1,026,000	$ 667,000	$ 2,575,000	$ 1,622,000